Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating lower radiotherapy doses for treating central nervous system germinoma in children; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Oncology Group | Conditions: Basal Ganglia Germinoma, Diabetes Insipidus | Phase 2 | Status: RECRUITING